Jamieson Wellness Inc.

Thank you. Thank you. Thank you. Thank you. Thank you.

Good afternoon, everyone. Welcome to the Jameson Wellness Conference call to discuss the financial results for the first quarter of 2026. At this time, all participants are in a listen-only mode. Later, we will conduct a question and answer session and instructions will be given at that time. Please be advised that the reproduction of this call in whole or in part is not permitted without written authorization from the company. As a reminder, today's call is being recorded. On the call today from management are Mike Pilaro, President and Chief Executive Officer, and Chris Snowden, Chief Financial Officer. Before I turn the call over to Mr. Pilaro, please note that a press release covering the company's first quarter financial results was issued this afternoon, and a copy of that press release can be found in the investor relations section of the company's website. Please note that the prepared remarks, which will follow, contain forward-looking statements. and management may make additional forward-looking statements in response to your questions. These statements do not guarantee future performance, and therefore, due reliance should not be placed upon them. We refer you to all risk factors contained in Gameston Press release issued this afternoon and in filings with the Canadian Securities Administrators for a more detailed discussion of the factors that could cause actual results to differ materially from those projections and any forward-looking statements. The company undertakes no obligation to publicly correct or update the forward-looking statements made during the presentation to reflect future events or circumstances, except as it may be required on the applicable securities laws. Finally, we would like to remind listeners that the company may refer to certain non-IFRS financial measures during this teleconference, a reconciliation to sorry, of these non-FIRs financial measures was included with the company's press release issued earlier today. Also, please note that unless otherwise stated, all features discussed today are in Canadian dollars and are occasionally grounded to the nearest million. I will now turn the call over to Mr. Pirarro to get started. Please go ahead, sir.

Thank you, Sergio, and good afternoon, everyone. Thanks for joining the call to discuss our first quarter 2026 results. I'll begin with some comments on our Q1 performance, our key markets, and our strategic growth initiatives. Then Chris will provide a detailed review of the financials and outlook before we open the call for questions. Q1 was another impressive quarter for Jameson Wellness, with branded revenue growth of almost 16%, reflecting continued momentum across each of our key markets. Consolidated revenue also grew just over 16%, and adjusted EBITDA grew by nearly 18%. The team delivered a strong start to the year. We drove growth across every business unit. The consumer continued to engage with our brands, and in-market innovation is performing in line with our expectations. The momentum we've created is poised to carry into the balance of the year. And just as important, we're continuing to balance that growth with disciplined investment consistent with the margin and cash flow framework we've laid out. Let me touch on how we performed across each of our markets. In China, revenue grew more than 55% on a constant currency basis in the quarter, reflecting increased consumer demand and disciplined execution by the team. We continue to see our baseline brand health improve and conversion to repeat purchasers increase. Locally relevant innovation and performance marketing, including a strong Women's Day promotional campaign, supported growth in what is typically a lower promotional quarter between our major June and 11-11 events. Overall, the flywheel we've been building from awareness to trial and trial to regular buyer continues to increase as intended. Moving to the U.S., as expected, we grew revenue almost 9% on a constant currency basis in the quarter, reflecting continued strength in e-commerce, and we're pleased with what we're seeing in our traditional channels as well, where we're continuing to see demand for our core hero products. Our e-commerce partnership continues to deliver to plan, with consistent quarter-over-quarter double-digit consumption gains, exactly as we laid out a year ago. We're excited about the trajectory of our U.S. business and Utheory's position in the market as the underlying positive trends continue. In Canada, revenue increased 4% in the quarter, lapping a very strong year-ago Q1 of double-digit growth in our home market, driven by the continued success of our quality-focused marketing campaign and strong innovation, including our new magnesium product. Our international business grew just over 20% in the quarter, led by continued strong consumption and solid execution across our priority markets. Underlying consumer demand remains healthy, and what continues to work for us internationally is locally relevant innovation paired with continued distribution gains, a scalable model as we lean further into the markets where our brand is most resonating. As we move through Q2, we're reaffirming our full-year 2026 outlook, which Chris will walk you through in a moment. The drivers we built our plan around are working. Our brands are gaining momentum across every major market, and the team is executing well. With that, I'll turn it over to Chris to walk through the financials in more detail.